Pipeline

Curative Biotechnology, Inc.

Curative Biotech currently has programs in 3 different therapeutic areas

Infectious Disease

Neuro Oncology

Degenerative Eye Disease

Candidate
Therapeutic Area
Indication
Preclinical
Phase 1
Phase 2
Phase 3
NDA Filed
Market
IMT504 Infectious Disease Late-Stage Rabies NA
CURB906 - CD56 Monoclonal Antibody and ADC Oncology Pediatric Glioblastoma
Metformin Reformulation Degenerative Eye Disease Stargardt Disease NA 505(b)(2) eligible
Metformin Reformulation Degenerative Eye Disease Retinitis Pigmentosa NA 505(b)(2) eligible
Metformin Reformulation Degenerative Eye Disease Choroidermia NA 505(b)(2) eligible
Metformin Reformulation Degenerative Eye Disease Late-Onset Retinal Degeneration NA 505(b)(2) eligible
Metformin Reformulation Degenerative Eye Disease Diabetic Retinopathy NA 505(b)(2) eligible
Metformin Reformulation Degenerative Eye Disease Age-Related Macular Degeneration NA 505(b)(2) eligible